Cherington Charles 13D and 13G filings for Eterna Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-22 12:05 pm Unchanged | 2023-12-14 | 13D | Eterna Therapeutics Inc. ERNA | Cherington Charles | 1,212,526 19.990% | 0 (Unchanged) | Filing |
| 2023-09-07 5:26 pm Purchase | 2023-07-13 | 13D | Eterna Therapeutics Inc. ERNA | Cherington Charles | 1,212,526 19.990% | 645,000 (+113.65%) | Filing |
| 2022-12-14 4:30 pm Purchase | 2022-12-02 | 13D | Eterna Therapeutics Inc. ERNA | Cherington Charles | 567,526 11.050% | 567,526 (New Position) | Filing |